Get an alert when BASF PHARMA (CALLANISH) LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

Latest balance sheet

Net assets

-£63m

-19.2% lowest in 3 filed years

Employees

72

-2.7% lowest in 3 filed years

Profit before tax

-£13m

-14.1% lowest in 3 filed years

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31

Metric Trend 2023-12-312024-12-312025-12-31 Δ vs prior
Turnover £18,875,000£11,507,000£14,618,000 +27%
Operating profit -£6,089,000-£7,444,000-£9,449,000 -26.9%
Profit before tax -£9,730,000-£11,805,000-£13,465,000 -14.1%
Net profit -£7,666,000-£8,828,000-£10,129,000 -14.7%
Cash
Total assets less current liabilities -£24,000,000-£2,828,000£12,254,000 +533.3%
Net assets -£44,000,000-£52,828,000-£62,957,000 -19.2%
Equity
Average employees 767472 -2.7%
Wages £3,207,000£3,203,000£3,347,000 +4.5%
Directors' remuneration

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-312025-12-31
Operating margin -32.3%-64.7%-64.6%
Net margin -40.6%-76.7%-69.3%
Return on capital employed -77.1%
Gearing (liabilities / total assets) 247.4%303.9%393.2%
Current ratio 0.35x0.54x1.28x
Interest cover -1.62x-1.69x-2.33x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. BASF PHARMA (CALLANISH) LIMITED 2012-05-15 → present
  2. EQUATEQ LIMITED 2005-07-13 → 2012-05-15

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Deloitte LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Consequently, the directors are confident that the company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 18 resigned

Name Role Appointed Born Nationality
CAMPBELL, Helen Victoria Secretary 2016-01-01
HOLSTEIN, Timothy Director 2023-09-01 Mar 1986 British
SCHWEITZER, Eva Maria, Dr Director 2025-06-01 Jan 1982 German
TAPLICK, Anne Else Director 2024-08-01 Jun 1984 German
Show 18 resigned officers
Name Role Appointed Resigned
HATTON, Stephen Secretary 2012-05-08 2015-12-31
KELLIHER, Cathra Secretary 2005-07-13 2012-05-08
RWL REGISTRARS LIMITED Corporate Nominee Secretary 2005-07-13 2005-07-13
BIRK, Thomas Director 2021-06-07 2025-04-01
BUDD, Darren, Dr Director 2025-04-01 2026-04-17
BUDD, Darren, Dr Director 2021-01-01 2021-06-07
CARTER, Richard John Director 2016-01-01 2020-12-31
FINK, Ralf Director 2013-09-01 2016-03-31
HARPER, Karen Lois Director 2017-05-12 2024-10-31
HATTON, Stephen Director 2012-05-08 2017-05-11
JENSEN, Torben Berlin Director 2012-05-08 2015-12-31
JONCKHEER, Frederik Jan Ludo Magdalena Director 2020-06-01 2020-11-01
KELLIHER, Adam Reginald Director 2005-07-13 2012-05-08
KELLIHER, Cathra Director 2005-07-13 2012-05-08
URWIN, Thomas Director 2012-05-08 2023-06-30
WASCHOLOWSKI, Veit, Dr Director 2021-02-16 2024-07-31
WIDMANN, Martin Director 2012-05-08 2013-08-31
RWL DIRECTORS LIMITED Corporate Director 2005-07-13 2005-07-13

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Basf Se Corporate entity Shares 75–100% 2016-04-06 Active

Filing timeline

Last 20 of 101 total filings

Date Type Category Description
2026-08-07 AA accounts Accounts with accounts type full
2026-07-27 CS01 confirmation-statement Confirmation statement with updates PDF
2026-07-17 AP01 officers Appoint person director company with name date PDF
2026-07-06 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-04-22 TM01 officers Termination director company with name termination date PDF
2026-01-08 CH03 officers Change person secretary company with change date PDF
2025-07-09 AA accounts Accounts with accounts type full
2025-07-08 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-06-11 AP01 officers Appoint person director company with name date PDF
2025-04-04 AP01 officers Appoint person director company with name date PDF
2025-04-03 TM01 officers Termination director company with name termination date PDF
2024-11-01 TM01 officers Termination director company with name termination date PDF
2024-09-10 AP01 officers Appoint person director company with name date PDF
2024-07-31 TM01 officers Termination director company with name termination date PDF
2024-07-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-04 AA accounts Accounts with accounts type full
2024-05-18 CH01 officers Change person director company with change date PDF
2023-09-20 AP01 officers Appoint person director company with name date PDF
2023-08-30 TM01 officers Termination director company with name termination date PDF
2023-07-12 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
6

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page